13F
中

VTGN VISTAGEN THERAPEUTICS INC

2026Q1 · CUSIP 92840H400 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
55
Δ holders QoQ
0
Breadth percentile
Top 62%
Whale holders
26
Δ whales
+2
Inst. holding value
$8M
New positions
16
Closed positions
16
Price momentum (1Q)
—
Put / Call
1/4

Breadth history (34 quarters)

2023Q3: Δ+2 · h=35 2023Q4: Δ+11 · h=46 2024Q1: Δ-3 · h=43 2024Q2: Δ+0 · h=43 2024Q3: Δ+5 · h=48 2024Q4: Δ+7 · h=55 2025Q1: Δ-5 · h=50 2025Q2: Δ+2 · h=52 2025Q3: Δ+6 · h=58 2025Q4: Δ-3 · h=55 2026Q1: Δ+0 · h=55 2023Q3: holders=35 2023Q4: holders=46 2024Q1: holders=43 2024Q2: holders=43 2024Q3: holders=48 2024Q4: holders=55 2025Q1: holders=50 2025Q2: holders=52 2025Q3: holders=58 2025Q4: holders=55 2026Q1: holders=55 -11 -5.5 +0 +5.5 +11 314661 23Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
1
QoQ: -3
Call holders
4
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.83
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+161.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $310100 2023-06-30: $177000 2023-09-30: $278000 2023-12-31: $411000 2024-03-31: $198000 2024-06-30: $84000 2024-09-30: $183000 2024-12-31: $234000 2025-03-31: $-15000 2025-06-30: $244000 2025-09-30: $258000 2025-12-31: $303000 2026-03-31: $464000 2023-12-31: EPS -0.22 2024-06-30: EPS -0.35 2024-09-30: EPS -0.42 2024-12-31: EPS -0.46 2025-03-31: EPS -0.44 2025-06-30: EPS -0.47 2025-09-30: EPS -0.54 2025-12-31: EPS -0.45 2026-03-31: EPS -0.37 0 232000 464000 $ -0.59 -0.30 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)